2791. Antimicrobial Activity of Cefiderocol and Comparator Agents Against Isolates of Pseudomonas aeruginosa, Acinetobacter baumannii-calcoaceticus species complex, and Stenotrophomonas maltophilia by Infection Type from United States Hospitals in the SENTRY Antimicrobial Surveillance Program (2020-2022)

BACKGROUND: Cefiderocol (CFDC) has broad in vitro activity against non–fermenting Gram-negative bacteria which often present treatment challenges due to multi-drug resistance. Stratified by infection type, the activity of CFDC and comparator agents was evaluated against Pseudomonas aeruginosa (PSA),...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Sean T, Valencia, Calbert, Bryowsky, Jason J, DeJonge, Boudewijn L, Maher, Joshua, Mendes, Rodrigo E, Takemura, Miki, Yamano, Yoshinori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677062/
http://dx.doi.org/10.1093/ofid/ofad500.2402

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677062/
http://dx.doi.org/10.1093/ofid/ofad500.2402

Ejemplares similares